SCHEMBL24626430

SCHEMBL24626430

c1ccc(-c2cc(-c3ccc(-c4cc(-c5ccccn5)nc(-c5cccc(-c6cc(-c7ccccc7)nc(-c7ccccc7)n6)n5)c4)cc3)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.55
LMNA P02545 5/20 0.55
SMN1; SMN2 Q16637 4/20 0.55
CCR1 P32246 3/20 0.55
CCR5 P51681 3/20 0.55
CCR8 P51685 3/20 0.55
TP53 P04637 3/20 0.55
MAPK1 P28482 2/20 0.55
L3MBTL1 Q9Y468 2/20 0.55
ALPL P05186 1/20 0.55
HSP90AA1 P07900 1/20 0.55
ALPI P09923 1/20 0.55
ALPG P10696 1/20 0.55
ALOX15 P16050 1/20 0.55
HTT P42858 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
MEN1 O00255 6/20 0.50
KMT2A Q03164 6/20 0.50
ALDH1A1 P00352 4/20 0.50
MAPT P10636 4/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24626433 1.00 KDM4E (0.55) KDM4ELMNASMN1; SMN2CCR1CCR5
SCHEMBL23081929 1.00 KDM4E (0.55) KDM4ELMNASMN1; SMN2CCR1CCR5
SCHEMBL24626276 0.98 KDM4E (0.53) KDM4ELMNASMN1; SMN2CCR1CCR5
SCHEMBL24626966 0.98 KDM4E (0.53) KDM4ELMNASMN1; SMN2CCR1CCR5
SCHEMBL24626452 0.98 KDM4E (0.53) KDM4ELMNASMN1; SMN2CCR1CCR5
SCHEMBL24626437 0.98 KDM4E (0.53) KDM4ELMNASMN1; SMN2CCR1CCR5
SCHEMBL24626735 0.98 KDM4E (0.53) KDM4ELMNASMN1; SMN2CCR1CCR5
SCHEMBL23081971 0.98 KDM4E (0.53) KDM4ELMNASMN1; SMN2CCR1CCR5
SCHEMBL24626916 0.98 KDM4E (0.53) KDM4ELMNASMN1; SMN2CCR1CCR5
SCHEMBL23081939 0.98 KDM4E (0.56) KDM4ELMNASMN1; SMN2CCR1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220223795-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2022-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220223795-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 KDM4E 2496/4885LMNA 3994/4885SMN1; SMN2 3932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.